Shares of Oklo surged as much as 13% to $47.67 after the advanced nuclear startup announced its Groves Isotope Test Reactor achieved first criticality — a controlled, self-sustaining chain reaction — at its Lockhart, Texas facility on the evening of August 5. The reactor went from an empty field to a working nuclear facility in roughly 11 months, or 229 days of active construction. The rally occurred against mixed broader markets, underscoring that this was a pure company-specific catalyst, amplified by Q2 earnings reported the following morning.

Building a Reactor in Under a Year Rewrites the Nuclear Playbook. The Groves reactor is the first under the DOE's Reactor Pilot Program to achieve criticality on private land, built from the ground up on a greenfield site.

This isn't a power plant — it's designed primarily to support isotope production and generate operational data for Oklo's future, larger-scale facilities. For investors, the speed matters more than the reactor itself: management argues the procedures, trained staff, and supply-chain relationships built at Groves can be copied to future projects, potentially compressing timelines industry-wide.

First Revenue Arrived, but Losses Are Accelerating. Oklo posted $1.2 million in Q2 revenue — far above the $83,800 forecast — but reported a loss of $0.28 per share versus the $0.16 analysts expected.

The $48.5 million net loss stepped up sharply from $33.1 million in Q1, signaling the company is accelerating spending rather than pulling back.

Full-year capital expenditure guidance was raised to $400 million–$500 million , reflecting procurement for the bigger prize: a 50–75 megawatt commercial power reactor at Idaho National Laboratory targeting a late-2027 to early-2028 startup.

A $3 Billion War Chest Buys Time — for Now. Oklo ended Q2 with roughly $3 billion in cash and marketable securities, including $1.6 billion in cash and $1.4 billion in securities , largely from $1.9 billion raised through stock sales in 2026. That dilution has built a cushion, but at current burn rates the runway is finite, and the Aurora power reactor still needs a combined NRC license before construction can begin.

The Real Test Is Still Ahead. The next major milestone is bringing the Aurora reactor at Idaho National Lab online, which would validate Oklo's commercial power platform.

With a market cap of $8.6 billion and a 52-week range of $36.61 to $193.84 , the stock prices in enormous future success. Groves proves Oklo can build. Whether it can build profitably — and at power-plant scale — remains the billion-dollar question.